Product category:
Clinical chemistry analysis
News Release from: Monobind | Subject: Chemiluminescense products
Edited by the Laboratorytalk Editorial
Team on 12 February 2003
Chemiluminescense diagnostic innovations
Range of products covers thyroid endocrinologies, reproductive endocrinologies, autoimmune disorders, cardio-vascular malfunctions and tumour markers
Monobind introduces a full line of diagnostic innovations using chemiluminescense technology in addition to the already existing line of products using Elisa technology The range of products covers thyroid endocrinologies, reproductive endocrinologies, autoimmune disorders, cardio-vascular malfunctions and tumour markers
Monobind signed an agreement in November 2002 with a German manufacturer to supply a cost-effective instrument to go with its products.
Monobind will supply a user friendly software system for use with Monobind products so the customer does not have to go through various programming steps.
The software will include provisions for plotting and storing QC trends for batch to batch consistency.
All Monobind products have a shelf life of 16 months at 2-8C.
• Monobind: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
